Back
ESC Premium Access

Docosahexaenoic acid acts as QT-shortening agent with genotype-specific beneficial effects in transgenic LQT1, LQT2, LQT5 and LQT2-5 rabbit models

Session: Best Posters 1 - Best Posters in ventricular arrythmias and SCD
Topic: Drug Treatment of Ventricular Arrhythmias
Speaker: Doctor A. Castiglione (Bern, CH)
Event: ESC Congress 2018

Congress Presentation

0

About the speaker

Doctor Alessandro Castiglione

Inselspital - University of Bern, Bern (Switzerland)
0 follower

4 more presentations in this session

Discussant : Best Posters in ventricular arrhythmias and SCD

Access
0
Thumbnail

SMART-MI risk-stratification algorithm: a prospective validation study

Speaker: Assistant Professor K. Rizas (Tuebingen, DE)

Access
Abstract
Slides
0
Thumbnail

The role of magnetic resonance in patients with premature ventricular contractions and normal findings at echocardiography

Speaker: Doctor R. Scorza (Stockholm, SE)

Access
Abstract
0
Thumbnail

Appropriate shocks and mortality in diabetic vs. non-diabetic patients with prophylactic implantable cardioverter-defibrillator

Speaker: Professor H. Huikuri (Oulu, FI)

Access
Abstract
0
Thumbnail

Access the full session

Best Posters 1 - Best Posters in ventricular arrythmias and SCD

Speakers: Doctor A. Castiglione, Assistant Professor K. Rizas, Doctor R. Scorza, Professor H. Huikuri
Access
0
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk